Megan Sniecinski's most recent trade in Biocryst Pharmaceuticals Inc. was a trade of 225,000 Emp. Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 15, 2020.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biocryst Pharmaceuticals Inc. | Megan Sniecinski | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2020 | 225,000 | 225,000 | - | - | Emp. Stock Option (Right to Buy) |